Fundraising Fox

BioHSV Holdings

Huntsville, US · Founded 2019 · Alabama corporation

Biotech

Founders & leadership

BK
Brian K. PollockNamed on SEC filing
KE
Katherine E. VarleyNamed on SEC filing
MJ
Michael J. WaltersNamed on SEC filing
JR
James R. Hudson, Jr.Named on SEC filing
DA
David A. KloskeNamed on SEC filing
DT
David T. MooreNamed on SEC filing
DW
Danny WindhamNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$5M disclosed across 2 of 3 rounds · 2019–2022

▶$2MraisedApr 2022 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David T. MooreExecutive Officer, Director
  • Michael J. WaltersDirector
  • Katherine E. VarleyDirector
  • Brian K. PollockExecutive Officer, Director
  • David A. KloskeExecutive Officer
  • Danny WindhamExecutive Officer, Director
  • James R. Hudson, Jr.Director
Offering amount
$3M
Amount sold
$2M
Minimum investment
$1
First sale
Apr 2022
Incorporated
Corporation, Alabama, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedJan 2021 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian K. PollockExecutive Officer, Director
  • Paul A. OwenExecutive Officer
  • David T. MooreExecutive Officer, Director
  • David A. KloskeExecutive Officer
  • James R. Hudson, Jr.Director
  • Katherine E. VarleyDirector
  • Michael J. WaltersDirector
  • Danny WindhamDirector
Offering amount
$3M
Amount sold
$3M
First sale
Jan 2021
Incorporated
Corporation, Alabama, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedNov 2019 · 29 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian K. PollockExecutive Officer, Director
  • Katherine E. VarleyDirector
  • Michael J. WaltersDirector
  • James R. Hudson, Jr.Director
  • David A. KloskeExecutive Officer
  • David T. MooreExecutive Officer, Director
  • Danny WindhamDirector
First sale
Oct 2019
Incorporated
Corporation, Alabama, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has BioHSV Holdings raised?
BioHSV Holdings has disclosed $5M raised across 2 of its 3 known rounds.
Where is BioHSV Holdings headquartered?
BioHSV Holdings is headquartered in Huntsville, US.